FLI-1 distinguishes ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma

Anna F. Lee, Malcolm M. Hayes, David Lebrun, Inigo Espinosa, G. Petur Nielsen, Andrew Rosenberg, Cheng Han Lee

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Small cell osteosarcoma and mesenchymal chondrosarcoma are 2 primary bone tumors with a small round blue cell component, which can mimic the appearance of Ewing sarcoma. Distinguishing these tumors from each other on biopsy material is important clinically, as optimal therapy differs according to the tumor type. However, separating these entities on morphology alone can be challenging. FLI-1 has been described to be a useful marker for Ewing sarcoma, particularly when hematolymphoid markers are negative. In small cell osteosarcoma and mesenchymal chondrosarcoma, the FLI-1 staining pattern has not been adequately characterized. Using a monoclonal FLI-1 antibody, nuclear immunoreactivity in tumor cells was evaluated in 10 small cell osteosarcomas, 10 mesenchymal chondrosarcomas, and 8 Ewing sarcomas, together with a number of other small, round, blue cell tumors. None of the small cell osteosarcomas or mesenchymal chondrosarcomas exhibited FLI-1 staining in the tumor cells, in contrast to the positive nuclear FLI-1 staining in the stromal endothelial cells. In comparison, 6 of the 8 Ewing sarcomas showed moderate-to-strong nuclear FLI-1 staining of the tumor cells in addition to strong staining of the stromal endothelial cell nuclei. With the exception of lymphoblastic lymphomas, FLI-1 positivity was not seen in the other small round blue cell tumors examined. These findings show that, in contrast to Ewing sarcoma, small cell osteosarcoma and mesenchymal chondrosarcoma lack FLI-1 immunoreactivity. FLI-1 is therefore useful in the differential diagnosis of small round blue cell tumors of the bone.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalApplied Immunohistochemistry and Molecular Morphology
Volume19
Issue number3
DOIs
StatePublished - May 1 2011
Externally publishedYes

Fingerprint

Mesenchymal Chondrosarcoma
Ewing's Sarcoma
Osteosarcoma
Neoplasms
Staining and Labeling
Stromal Cells
Endothelial Cells
Bone and Bones
Cellular Structures
Cell Nucleus
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Keywords

  • ewing sarcoma
  • FLI-1
  • immunohistochemistry
  • mesenchymal chondrosarcoma
  • small cell osteosarcoma
  • small round blue cell tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology
  • Histology

Cite this

FLI-1 distinguishes ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. / Lee, Anna F.; Hayes, Malcolm M.; Lebrun, David; Espinosa, Inigo; Nielsen, G. Petur; Rosenberg, Andrew; Lee, Cheng Han.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 19, No. 3, 01.05.2011, p. 233-238.

Research output: Contribution to journalArticle

Lee, Anna F. ; Hayes, Malcolm M. ; Lebrun, David ; Espinosa, Inigo ; Nielsen, G. Petur ; Rosenberg, Andrew ; Lee, Cheng Han. / FLI-1 distinguishes ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. In: Applied Immunohistochemistry and Molecular Morphology. 2011 ; Vol. 19, No. 3. pp. 233-238.
@article{2a746c15934247f5b4969f79005163d7,
title = "FLI-1 distinguishes ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma",
abstract = "Small cell osteosarcoma and mesenchymal chondrosarcoma are 2 primary bone tumors with a small round blue cell component, which can mimic the appearance of Ewing sarcoma. Distinguishing these tumors from each other on biopsy material is important clinically, as optimal therapy differs according to the tumor type. However, separating these entities on morphology alone can be challenging. FLI-1 has been described to be a useful marker for Ewing sarcoma, particularly when hematolymphoid markers are negative. In small cell osteosarcoma and mesenchymal chondrosarcoma, the FLI-1 staining pattern has not been adequately characterized. Using a monoclonal FLI-1 antibody, nuclear immunoreactivity in tumor cells was evaluated in 10 small cell osteosarcomas, 10 mesenchymal chondrosarcomas, and 8 Ewing sarcomas, together with a number of other small, round, blue cell tumors. None of the small cell osteosarcomas or mesenchymal chondrosarcomas exhibited FLI-1 staining in the tumor cells, in contrast to the positive nuclear FLI-1 staining in the stromal endothelial cells. In comparison, 6 of the 8 Ewing sarcomas showed moderate-to-strong nuclear FLI-1 staining of the tumor cells in addition to strong staining of the stromal endothelial cell nuclei. With the exception of lymphoblastic lymphomas, FLI-1 positivity was not seen in the other small round blue cell tumors examined. These findings show that, in contrast to Ewing sarcoma, small cell osteosarcoma and mesenchymal chondrosarcoma lack FLI-1 immunoreactivity. FLI-1 is therefore useful in the differential diagnosis of small round blue cell tumors of the bone.",
keywords = "ewing sarcoma, FLI-1, immunohistochemistry, mesenchymal chondrosarcoma, small cell osteosarcoma, small round blue cell tumor",
author = "Lee, {Anna F.} and Hayes, {Malcolm M.} and David Lebrun and Inigo Espinosa and Nielsen, {G. Petur} and Andrew Rosenberg and Lee, {Cheng Han}",
year = "2011",
month = "5",
day = "1",
doi = "10.1097/PAI.0b013e3181fd6697",
language = "English",
volume = "19",
pages = "233--238",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - FLI-1 distinguishes ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma

AU - Lee, Anna F.

AU - Hayes, Malcolm M.

AU - Lebrun, David

AU - Espinosa, Inigo

AU - Nielsen, G. Petur

AU - Rosenberg, Andrew

AU - Lee, Cheng Han

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Small cell osteosarcoma and mesenchymal chondrosarcoma are 2 primary bone tumors with a small round blue cell component, which can mimic the appearance of Ewing sarcoma. Distinguishing these tumors from each other on biopsy material is important clinically, as optimal therapy differs according to the tumor type. However, separating these entities on morphology alone can be challenging. FLI-1 has been described to be a useful marker for Ewing sarcoma, particularly when hematolymphoid markers are negative. In small cell osteosarcoma and mesenchymal chondrosarcoma, the FLI-1 staining pattern has not been adequately characterized. Using a monoclonal FLI-1 antibody, nuclear immunoreactivity in tumor cells was evaluated in 10 small cell osteosarcomas, 10 mesenchymal chondrosarcomas, and 8 Ewing sarcomas, together with a number of other small, round, blue cell tumors. None of the small cell osteosarcomas or mesenchymal chondrosarcomas exhibited FLI-1 staining in the tumor cells, in contrast to the positive nuclear FLI-1 staining in the stromal endothelial cells. In comparison, 6 of the 8 Ewing sarcomas showed moderate-to-strong nuclear FLI-1 staining of the tumor cells in addition to strong staining of the stromal endothelial cell nuclei. With the exception of lymphoblastic lymphomas, FLI-1 positivity was not seen in the other small round blue cell tumors examined. These findings show that, in contrast to Ewing sarcoma, small cell osteosarcoma and mesenchymal chondrosarcoma lack FLI-1 immunoreactivity. FLI-1 is therefore useful in the differential diagnosis of small round blue cell tumors of the bone.

AB - Small cell osteosarcoma and mesenchymal chondrosarcoma are 2 primary bone tumors with a small round blue cell component, which can mimic the appearance of Ewing sarcoma. Distinguishing these tumors from each other on biopsy material is important clinically, as optimal therapy differs according to the tumor type. However, separating these entities on morphology alone can be challenging. FLI-1 has been described to be a useful marker for Ewing sarcoma, particularly when hematolymphoid markers are negative. In small cell osteosarcoma and mesenchymal chondrosarcoma, the FLI-1 staining pattern has not been adequately characterized. Using a monoclonal FLI-1 antibody, nuclear immunoreactivity in tumor cells was evaluated in 10 small cell osteosarcomas, 10 mesenchymal chondrosarcomas, and 8 Ewing sarcomas, together with a number of other small, round, blue cell tumors. None of the small cell osteosarcomas or mesenchymal chondrosarcomas exhibited FLI-1 staining in the tumor cells, in contrast to the positive nuclear FLI-1 staining in the stromal endothelial cells. In comparison, 6 of the 8 Ewing sarcomas showed moderate-to-strong nuclear FLI-1 staining of the tumor cells in addition to strong staining of the stromal endothelial cell nuclei. With the exception of lymphoblastic lymphomas, FLI-1 positivity was not seen in the other small round blue cell tumors examined. These findings show that, in contrast to Ewing sarcoma, small cell osteosarcoma and mesenchymal chondrosarcoma lack FLI-1 immunoreactivity. FLI-1 is therefore useful in the differential diagnosis of small round blue cell tumors of the bone.

KW - ewing sarcoma

KW - FLI-1

KW - immunohistochemistry

KW - mesenchymal chondrosarcoma

KW - small cell osteosarcoma

KW - small round blue cell tumor

UR - http://www.scopus.com/inward/record.url?scp=79955068165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955068165&partnerID=8YFLogxK

U2 - 10.1097/PAI.0b013e3181fd6697

DO - 10.1097/PAI.0b013e3181fd6697

M3 - Article

VL - 19

SP - 233

EP - 238

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 3

ER -